Unlock stock picks and a broker-level newsfeed that powers Wall Street.

BriaCell Therapeutics Down 17% In US Premarket As Prices US$13.8 Million Public Offering

In This Article:

BriaCell Therapeutics (BCT.TO, BCTX) was down 17% at last look in US premarket trade after it overni

Upgrade to read this MT Newswires article and get so much more.
A Silver or Gold subscription plan is required to access premium news articles.